A new prescription app and delivery service has been launched to try to combat poor patient prescription compliance. The new system, developed by Auckland-based Zoom Health, allows GPs to send
Novartis confirmed it will spin-off its eye care division, Alcon, to shareholders and complete a share buyback of up to US$5 billion by the end of 2019, funded mainly by selling its stake in its consumer health joint venture, to focus on its prescription drug business.
On behalf of Macular Degeneration New Zealand (MDNZ), trustee and Tauranga-based ophthalmologist, Dr Andrew Thompson, met with the Health Minister, David Clark in June.
A study in Japan, led by Professor Shigeru Kinoshita from Kyoto Prefectural University of Medicine, has shown cultured human corneal endothelial cells (CECs) injected into the anterior chamber could increase CEC density, providing a possible alternative to donor tissue and avoiding many of the compl
Dr Lola Mugisho was awarded a Dean’s List placement from the University of Auckland in recognition of excellence achieved for her PhD thesis, Vascular breakdown in diabetic retinopathy: role of connexin43 and possible interventions.
Stepping into the media spotlight himself, well-known TV news journalist Patrick Gower dug deep and shared his own personal battle with glaucoma in support of Glaucoma New Zealand’s (GNZ’s) 2018 July appeal, ‘Light up Glaucoma’.
Dr Emilio de Almeida Torres Netto from Brazil has won the first International Council of Ophthalmology (ICO)-Allergan Advanced Research Fellowship to further his work in cornea biomechanics and keratoconus.
Four Counties Manukau District Health Board (CMDHB) ‘mega-clinics’ saw more than 550 patients, but there is still more to be done, said Dr Simon Dean, CMDHB ophthalmology clinical leader.Answering
A simple blood test to diagnose and track the progression of uveal melanoma is showing promising results in studies by researchers from Western Australia’s Edith Cowan University (ECU). At present, the classification of uveal melanoma types is achieved by obtaining a sample from the tumour in the ey
Since launching in New Zealand in January this year, an estimated 25% of New Zealand’s independent optometry market has signed up to MyHealth1st’s online appointment booking system.
The global eyecare and eye bank community has unveiled the world’s first global agreement on the use of donated human tissue for ocular transplantation, research, and future technologies.Named the
Alcon’s new Clareon AutonoMe intraocular lens (IOL) and delivery system was launched in Australia and New Zealand on 30 June at its Synergeyes Clinical Symposium in Sydney. AutonoMe is the first and only automated, disposable, preloaded IOL delivery system, said Alcon in a statement, enabling easy,
